Doctor Yu He
University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
Developing p21-activated kinase 1 (PAK1) activators to treat hypertrophic cardiomyopathy (HCM)
Event: ESC Congress 2024
Topic: Cardiovascular Pharmacotherapy
Session: Biotherapies in cardiovascular disease: from bench to bedside
